The FDA’s regulatory process is the major reason and a report calls it a threat to investment to U.S. medical innovation
Visit link:
VCs to Stem Med-Tech Investment
If you enjoyed this post, make sure you subscribe to my RSS feed!
The FDA’s regulatory process is the major reason and a report calls it a threat to investment to U.S. medical innovation
Visit link:
VCs to Stem Med-Tech Investment
Tagged with: america arlington been-the-leader chairwoman commissioner entrepreneurs european financial health imperative innovation kleiner-perkins medical obama secretary